Cargando…
Targeted Treatment Options in Mastocytosis
Mastocytosis refers to a heterogeneous group of disorders resulting from the clonal proliferation of abnormal mast cells and their accumulation in the skin (cutaneous mastocytosis when only in the skin, CM) or in various organs (systemic mastocytosis, SM). This leads to a wide variety of clinical ma...
Autores principales: | Vaes, Mélanie, Benghiat, Fleur Samantha, Hermine, Olivier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5517467/ https://www.ncbi.nlm.nih.gov/pubmed/28775983 http://dx.doi.org/10.3389/fmed.2017.00110 |
Ejemplares similares
-
Clinical potential of midostaurin in advanced systemic mastocytosis
por: Chandesris, Marie Olivia, et al.
Publicado: (2017) -
Recent advances in the understanding and therapeutic management of mastocytosis
por: Rossignol, Julien, et al.
Publicado: (2019) -
A Case of Systemic Mastocytosis Diagnosed Endoscopically
por: Tagliaferri, Ariana R, et al.
Publicado: (2022) -
The Effectiveness and Safety of Pharmaceutical-Grade Cannabidiol in the Treatment of Mastocytosis-Associated Pain: A Pilot Study
por: Rossignol, Julien, et al.
Publicado: (2023) -
Mastocytosis: a rare clinical image
por: Chitmulwar, Vaibhavi, et al.
Publicado: (2023)